Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Envisioning trans-inclusive and trans-specific cancer care

Nature Reviews Clinical Oncology volume 20, pages 351–352 (2023)Cite this article

Subjects

Transgender patients are a marginalized group for whom current standards of oncology have yet to be optimized. In this Comment, we highlight opportunities for transgender-inclusive and transgender-specific practices across the cancer care continuum and identify evidence gaps that will need to be filled to attain optimal care for transgender populations.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Stanford University Vaden Health Services. Glossary of terms related to transgender communities. vaden.stanford.edu, https://vaden.stanford.edu/medical-services/lgbtqia-health/glossary-terms-related-transgender-communities (accessed 23 March 2023).

  2. White Hughto, J. M., Reisner, S. L. & Pachankis, J. E. Transgender stigma and health: a critical review of stigma determinants, mechanisms, and interventions. Soc. Sci. Med. 147, 222–231 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  3. Restar, A., Jin, H. & Operario, D. Gender-inclusive and gender-specific approaches in trans health research. Transgender Health 6, 235–239 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  4. Grasso, C. et al. Required sexual orientation and gender identity reporting by US health centers: first-year data. Am. J. Public Health 109, 1111–1118 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  5. de Blok, C. J. M. et al. Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands. Brit. Med. J. 365, l1652 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Weyers, S. et al. Mammography and breast sonography in transsexual women. Eur. J. Radiol. 74, 508–513 (2010).

    Article  CAS  PubMed  Google Scholar 

  7. Dhillon, N., Oliffe, J. L., Kelly, M. T. & Krist, J. Bridging barriers to cervical cancer screening in transgender men: a scoping review. Am. J. Mens Health 14, 1557988320925691 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  8. Seay, J. et al. Understanding transgender men’s experiences with and preferences for cervical cancer screening: a rapid assessment survey. LGBT Health 4, 304–309 (2017).

    Article  PubMed  Google Scholar 

  9. Agénor, M. et al. Gender-related health care discrimination and human papillomavirus vaccination among transgender and nonbinary young adults in the United States. Transgender Health https://doi.org/10.1089/trgh.2021.0077 (2022).

    Article  Google Scholar 

  10. Kcomt, L., Gorey, K. M., Barrett, B. J. & McCabe, S. E. Healthcare avoidance due to anticipated discrimination among transgender people: a call to create trans-affirmative environments. SSM - Popul Health. 11, 100608 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  11. Jackson Levin, N., Kattari, S. K., Piellusch, E. K. & Watson, E. “We just take care of each other”: navigating ‘chosen family’ in the context of health, illness, and the mutual provision of care amongst queer and transgender young adults. Int. J. Environ. Res. Public Health 17, 7346 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Applied Transgender Studies, Chicago, IL, USA

    Elle Lett

  2. Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

    Elle Lett

  3. Division of Hematology & Oncology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA

    Joannie M. Ivory

  4. Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

    Joannie M. Ivory & Mya L. Roberson

  5. Department of Health Policy and Management, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

    Mya L. Roberson

Authors
  1. Elle Lett
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joannie M. Ivory
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mya L. Roberson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mya L. Roberson.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lett, E., Ivory, J.M. & Roberson, M.L. Envisioning trans-inclusive and trans-specific cancer care. Nat Rev Clin Oncol 20, 351–352 (2023). https://doi.org/10.1038/s41571-023-00764-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41571-023-00764-z

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer